サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1530518

ヒトミルクオリゴ糖の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2024年～2030年

Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Type (2'FL, 3'FL, 3'SL, 6'SL, LNT), By Application (Infant Formula), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 146 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒトミルクオリゴ糖の市場規模、シェア、動向分析レポート：タイプ別、用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年07月26日
発行: Grand View Research
ページ情報: 英文 146 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒトミルクオリゴ糖市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヒトミルクオリゴ糖市場規模は、20254年から2030年にかけて13.8%のCAGRを記録し、2030年までに7億3,223万米ドルに達すると予測されています。

市場成長の主な要因は、栄養補助食品に対する需要の高まりと、腸内健康の重要性に関する消費者の意識の高まりです。ヒトミルクオリゴ糖（HMO）は、人体内でプレバイオティクスとして作用するため、腸の健康を維持する上で極めて重要です。腸内の有益な細菌、特にビフィズス菌の増殖を促進することにより、HMOは代謝活性を高め、全体的な健康に寄与します。HMOの利点に対する認識の高まりは、引き続き市場の成長を促進します。

さらに、HMOの抗菌保護およびプレバイオティクス特性により、HMOは乳児用調製粉乳、医薬品、機能性食品など様々な食品に組み込むことができる万能成分であり、その需要を促進しています。HMOの市場は、乳児栄養、脳発達、記憶力強化、および疾病予防における不可欠な役割によってさらに強化されます。さらに、合成生産方法の進歩は、母乳育児が不可能な状況に対応し、母乳以外のHMOの利用可能性を拡大しました。消費者の意識が高まり続け、プレバイオティクスが豊富な製品に対する需要が高まるにつれて、ヒトミルクオリゴ糖の市場は、さまざまな年齢層にわたるそのユニークな健康上の利点に牽引され、持続的な成長を示すと予想されます。

ヒトミルクオリゴ糖市場レポート・ハイライト

  • 乳児用調製乳および他の母乳代替品への高い需要と規制当局の承認増加により、2023年には2'FL HMOが44.6%のシェアを占めました。
  • DFL分野は2024年から2030年までのCAGRが20.0%と予測されます。これは、乳幼児と成人におけるDFLの潜在的な健康効果に関する研究開発が活発化しているためです。
  • 乳児用調製粉乳分野は、2023年には90.7%のシェアを占めました。乳児用調製粉乳の設計におけるHMOの需要は、腸の健康改善、記憶力強化、脳の発達、感染予防、プレビオティック効果などの有益な特性により増加しています。
  • 栄養補助食品分野は、2024年から2030年にかけて18.3%のCAGRが見込まれます。個別化栄養への関心の高まりが、栄養補助食品におけるHMOの需要、天然で機能的な成分への欲求、早期栄養の重要性の認識を促進します。
  • 2023年には、欧州の市場シェアは78.5%でした。欧州市場は、HMOがヒトの母乳の組成を模倣し、それによって乳児に多くの健康上の利点を提供するとの理解に後押しされて、HMOを強化した製品を選ぶ親が増加していることを特徴としています。
  • アジア太平洋は、2024年から2030年までCAGR 20.5%で成長すると予想されます。高栄養食品とより良い消化器系の健康に対する需要が、この地域市場を牽引しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒトミルクオリゴ糖市場の変数、動向、範囲

  • 市場イントロダクション
  • 浸透と成長の見込みマッピング
    • 市場浸透
    • 成長の見通し
  • 業界バリューチェーン分析
    • 製造と技術の展望
    • 利益率分析
  • 規制の枠組み
    • 米国
    • 欧州連合
    • 中国
    • オーストラリアとニュージーランド
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
    • 業界の課題
    • 業界の機会
  • 業界分析
    • ポーターのファイブフォース分析
    • PESTEL分析
  • 市場参入戦略
  • 国別平均販売価格、2023年
    • 2023年のタイプ別平均販売価格
    • 平均販売価格、用途別、2023年

第4章 ヒトミルクオリゴ糖市場：タイプ別分析と推定

  • タイプ別分析と市場シェア、2023年と2030年
  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL
  • LNT
  • LNnT
  • DFL

第5章 ヒトミルクオリゴ糖市場：用途別推定・動向分析

  • 用途別変動分析と市場シェア、2023年と2030年
  • 食品・飲料
  • 栄養補助食品
  • 乳児用調製粉乳
  • 医薬品
  • 脂肪燃焼剤

第6章 ヒトミルクオリゴ糖市場：地域別推定・動向分析

  • 地域別変動分析と市場シェア、2023年と2030年
  • 北米
    • 市場推計・予測、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 市場推計・予測、2018年-2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 市場推計・予測、2018年-2030年
    • 中国
    • インド
    • 日本
    • 台湾
    • 韓国
    • ベトナム
    • インドネシア
    • フィリピン
    • マレーシア
    • シンガポール
  • 中南米
    • 市場推計・予測、2018年-2030年
    • ブラジル
  • 中東・アフリカ
    • 市場推計・予測、2018年-2030年
    • 南アフリカ

第7章 競合分析

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • 参入企業の概要
  • 財務実績
  • 製品ベンチマーク
  • 企業市場シェア分析、2023年（％）
  • 企業ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル
  • Glycom A/S
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Chr. Hansen Holding A/S
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Kyowa Hakko Europe GmbH
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • FrieslandCampina Ingredients
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • BASF SE
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Dextra Laboratories Limited
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Inboise NV
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • Biosynth Limited
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • ELICITYL SA
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • ZuChem Inc.
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
  • RAJVI ENTERPRISE
    • 会社概要
    • 財務実績
    • 製品ベンチマーク
    • 戦略的取り組み
図表

List of Tables

  • 1. Comparison of HMOs approval status in various countries/regions
  • 2. Average Selling Price, by Country, 2023 (USD/Ton)
  • 3. Average Selling Price, by Type, 2023 (USD/Ton)
  • 4. Average Selling Price, by Application, 2023 (USD/Ton)
  • 5. Human milk oligosaccharides market estimates & forecast, by type (USD Million)
  • 6. Human milk oligosaccharides market estimates & forecast, by type (Tons)
  • 7. Human milk oligosaccharides market estimates & forecast by application (USD Million)
  • 8. Human milk oligosaccharides market estimates & forecast by application (Tons)
  • 9. U.S. macro-economic outlay
  • 10. Canada macro-economic outlay
  • 11. Mexico macro-economic outlay
  • 12. U.K. macro-economic outlay
  • 13. Germany macro-economic outlay
  • 14. France macro-economic outlay
  • 15. Italy macro-economic outlay
  • 16. Spain macro-economic outlay
  • 17. China macro-economic outlay
  • 18. Japan macro-economic outlay
  • 19. India macro-economic outlay
  • 20. Taiwan macro-economic outlay
  • 21. South Korea macro-economic outlay
  • 22. Vietnam macro-economic outlay
  • 23. Indonesia macro-economic outlay
  • 24. Philippines macro-economic outlay
  • 25. Malaysia macro-economic outlay
  • 26. Singapore macro-economic outlay
  • 27. Brazil macro-economic outlay
  • 28. South Africa macro-economic outlay

List of Figures

  • 1. Human milk oligosaccharides market segmentation
  • 2. Information procurement
  • 3. Primary research pattern
  • 4. Primary research approaches
  • 5. Primary research process
  • 6. Market snapshot
  • 7. Type segment snapshot
  • 8. Application segment snapshot
  • 9. Competitive landscape snapshot
  • 10. Global human milk oligosaccharides market size, 2018 to 2030 (USD Million)
  • 11. Global human milk oligosaccharides market: Penetration & growth prospect mapping for applications
  • 12. Global human milk oligosaccharides market: Value chain analysis (1/2)
  • 13. Global human milk oligosaccharides market: Value chain analysis (2/2)
  • 14. Global human milk oligosaccharides market: Profit margin analysis
  • 15. Human milk oligosaccharides market: Dynamics
  • 16. A roadmap of HMO development, 1886-2020
  • 17. Impact of high costs on various related industries
  • 18. Global human milk oligosaccharides market: Porter's five force analysis
  • 19. Global human milk oligosaccharides market: PESTEL analysis
  • 20. Human milk oligosaccharides market, by type: Key takeaways
  • 21. Human milk oligosaccharides market, by type: Market share, 2023 & 2030
  • 22. Human milk oligosaccharides market, by type: Key takeaways
  • 23. Human milk oligosaccharides market, by type: Market share, 2023 & 2030
  • 24. 2'FL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 25. 2'FL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 26. 3'FL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 27. 3'FL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 28. 3'SL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 29. 3'SL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 30. 6'SL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 31. 6'SL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 32. LNT human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 33. LNT human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 34. LNnT human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 35. LNnT human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 36. DFL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (USD Million)
  • 37. DFL human milk oligosaccharides market estimates & forecasts, 2018 - 2030 (Tons)
  • 38. Human milk oligosaccharides market, by application: Key takeaways
  • 39. Human milk oligosaccharides market, by application: Market share, 2023 & 2030
  • 40. Human milk oligosaccharides market, by application: Key takeaways
  • 41. Human milk oligosaccharides market, by application: Market share, 2023 & 2030
  • 42. Human milk oligosaccharides market estimates & forecasts, in food & beverages, 2018 - 2030 (USD Million)
  • 43. Human milk oligosaccharides market estimates & forecasts, in food & beverages, 2018 - 2030 (Tons)
  • 44. Human milk oligosaccharides market estimates and forecasts in dietary supplements, 2018 - 2030 (USD Million)
  • 45. Human milk oligosaccharides market estimates and forecasts in dietary supplements, 2018 - 2030 (Tons)
  • 46. Human milk oligosaccharides market estimates and forecasts in infant formula, 2018 - 2030 (USD Million)
  • 47. Human milk oligosaccharides market estimates and forecasts in infant formula, 2018 - 2030 (Tons)
  • 48. Human milk oligosaccharides market estimates and forecasts in pharmaceuticals, 2018 - 2030 (USD Million)
  • 49. Human milk oligosaccharides market estimates and forecasts in pharmaceuticals, 2018 - 2030 (Tons)
  • 50. Human milk oligosaccharides market revenue, by region, 2023 & 2030, (USD Million)
  • 51. Regional marketplace: Key takeaways (1/2)
  • 52. Regional marketplace: Key takeaways (2/2)
  • 53. North America human milk oligosaccharides market estimates & forecast, 2018- 2030, (USD Million)
  • 54. North America human milk oligosaccharides market estimates & forecast, 2018- 2030, (Tons)
  • 55. U.S. human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 56. U.S. human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 57. Canada human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 58. Canada human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 59. Mexico human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 60. Mexico human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 61. Europe human milk oligosaccharides market estimates & forecast, 2018- 2030, (USD Million)
  • 62. Europe human milk oligosaccharides market estimates & forecast, 2018- 2030, (Tons)
  • 63. U.K. human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 64. U.K. human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 65. Germany human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 66. Germany human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 67. France human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 68. France human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 69. Italy human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 70. Italy human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 71. Spain human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 72. Spain human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 73. Asia Pacific human milk oligosaccharides market estimates & forecast, 2018- 2030, (USD Million)
  • 74. Asia Pacific human milk oligosaccharides market estimates & forecast, 2018- 2030, (Tons)
  • 75. China human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 76. China human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 77. Japan human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 78. Japan human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 79. India human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 80. India human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 81. Taiwan human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 82. Taiwan human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 83. South Korea human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 84. South Korea human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 85. Vietnam human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 86. Vietnam human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 87. Indonesia human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 88. Indonesia human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 89. Philippines human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 90. Philippines human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 91. Malaysia human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 92. Malaysia human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 93. Singapore human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 94. Singapore human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 95. Central & South America human milk oligosaccharides market estimates & forecast, 2018- 2030, (USD Million)
  • 96. Central & South America human milk oligosaccharides market estimates & forecast, 2018- 2030, (Tons)
  • 97. Brazil human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 98. Brazil human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
  • 99. Middle East & Africa human milk oligosaccharides market estimates & forecast, 2018- 2030, (USD Million)
  • 100. Middle East & Africa human milk oligosaccharides market estimates & forecast, 2018- 2030, (Tons)
  • 101. South Africa human milk oligosaccharides market estimates & forecast, 2018 - 2030 (USD Million)
  • 102. South Africa human milk oligosaccharides market estimates & forecast, 2018 - 2030 (Tons)
目次
Product Code: 978-1-68038-608-0

Human Milk Oligosaccharides Market Growth & Trends:

The global human milk oligosaccharides market size is expected to reach USD 732.23 million by 2030, registering a CAGR of 13.8% from 20254 to 2030, according to a new report by Grand View Research, Inc. The market growth is primarily driven by the rising demand for dietary supplements and an increasing awareness among consumers regarding the significance of gut health. Human milk oligosaccharides (HMOs) are crucial in maintaining gut health as they act as prebiotics in the human body. By promoting the growth of beneficial bacteria, particularly bifidobacteria, in the gut, HMOs enhance metabolic activity and contribute to overall well-being. The increasing recognition of HMO benefits continues to drive market growth.

Moreover, the antimicrobial protection and prebiotic properties of HMOs make them versatile ingredients that can be incorporated into various food products, such as infant formulas, pharmaceuticals, and functional foods, driving their demand. The market for HMOs is further bolstered by their essential role in infant nutrition, brain development, memory enhancement, and disease prevention. Furthermore, advancements in synthetic production methods have expanded the availability of HMOs beyond breast milk, catering to situations where breastfeeding may not be feasible. As consumer awareness continues to rise and demand for prebiotic-rich products escalates, the market for human milk oligosaccharides is expected to witness sustained growth driven by their unique health benefits across different age groups.

Human Milk Oligosaccharides Market Report Highlights:

  • 2'FL HMOs held a share of 44.6% in 2023 due to the high demand for infant formula and other breast milk substitutes and a rise in regulatory approvals
  • The DFL segment is expected to witness a CAGR of 20.0% from 2024 to 2030. This can be attributed to growing research and developments regarding the potential health benefits of DFL in infants and adults
  • The infant formula segment held a share of 90.7% in 2023. The demand for HMOs in designing infant formulas is increasing due to their beneficial properties, such as improving gut health, memory enhancement, brain development, prevention of infection, and prebiotic effects
  • The dietary supplements segment is anticipated to witness a CAGR of 18.3% from 2024 to 2030. The growing interest in personalized nutrition drives the demand for HMOs in dietary supplements, the desire for natural and functional ingredients, and the recognition of the importance of early-life nutrition
  • In 2023, Europe held a market share of 78.5%. The European market is characterized by a growing number of parents opting for products enriched with HMO, driven by the understanding that HMOs mimic the composition of human breast milk, thereby offering numerous health benefits to infants
  • Asia Pacific is expected to grow at a CAGR of 20.5% from 2024 to 2030. The demand for high-nutrition foods and better digestive health are driving the regional market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Ingredient Outlook
  • 2.3. Type Outlook
  • 2.4. Application Outlook
  • 2.5. Regional Outlook
  • 2.6. Competitive Insights

Chapter 3. Human Milk Oligosaccharides Market Variables, Trends & Scope

  • 3.1. Market Introduction
  • 3.2. Penetration & Growth Prospect Mapping
    • 3.2.1. Market Penetration
    • 3.2.2. Growth Prospect
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Manufacturing And Technology Outlook
    • 3.3.2. Profit Margin Analysis
  • 3.4. Regulatory Framework
    • 3.4.1. U.S.
    • 3.4.2. EU
    • 3.4.3. China
    • 3.4.4. Australia and New Zealand
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Industry Challenges
    • 3.5.4. Industry Opportunities
  • 3.6. Industry Analysis
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL Analysis
  • 3.7. Market Entry Strategies
  • 3.8. Average Selling Price, by Country, 2023 (USD/Ton)
    • 3.8.1. Average Selling Price, By Type, 2023 (USD/Ton)
    • 3.8.2. Average Selling Price, By Application, 2023 (USD/Ton)

Chapter 4. Human Milk Oligosaccharides Market: Type Analysis & Estimates

  • 4.1. Type Analysis & Market Share, 2023 & 2030
  • 4.2. 2'FL
    • 4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.3. 3'FL
    • 4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4. 3'SL
    • 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. 6'SL
    • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. LNT
    • 4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.7. LNnT
    • 4.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.8. DFL
    • 4.8.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Human Milk Oligosaccharides Market: Application Estimates & Trend Analysis

  • 5.1. Application Movement Analysis & Market Share, 2023 & 2030
  • 5.2. Food & Beverages
    • 5.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.3. Dietary Supplements
    • 5.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Infant Formula
    • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Pharmaceuticals
    • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Fat Burners
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Human Milk Oligosaccharides Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Movement Analysis & Market Share, 2023 & 2030
  • 6.2. North America
    • 6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key country dynamics
      • 6.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key country dynamics
      • 6.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key country dynamics
      • 6.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.3. U.K.
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key country dynamics
      • 6.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key country dynamics
      • 6.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.3. India
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.5. Taiwan
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.7. Vietnam
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.8. Indonesia
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.9. Philippines
      • 6.4.9.1. Key country dynamics
      • 6.4.9.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.10. Malaysia
      • 6.4.10.1. Key country dynamics
      • 6.4.10.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.4.11. Singapore
      • 6.4.11.1. Key country dynamics
      • 6.4.11.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Central & South America
    • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Competitive Analysis

  • 7.1. Recent developments & impact analysis, by key market participants
  • 7.2. Company Categorization
  • 7.3. Participant's Overview
  • 7.4. Financial Performance
  • 7.5. Product Benchmarking
  • 7.6. Company Market Share Analysis, 2023 (%)
  • 7.7. Company Heat Map Analysis
  • 7.8. Strategy Mapping
  • 7.9. Company Profiles
  • 7.10. Glycom A/S
    • 7.10.1. Company Overview
    • 7.10.2. Financial Performance
    • 7.10.3. Product Benchmarking
    • 7.10.4. Strategic Initiatives
  • 7.11. Chr. Hansen Holding A/S
    • 7.11.1. Company Overview
    • 7.11.2. Financial Performance
    • 7.11.3. Product Benchmarking
    • 7.11.4. Strategic Initiatives
  • 7.12. Kyowa Hakko Europe GmbH
    • 7.12.1. Company Overview
    • 7.12.2. Financial Performance
    • 7.12.3. Product Benchmarking
    • 7.12.4. Strategic Initiatives
  • 7.13. FrieslandCampina Ingredients
    • 7.13.1. Company Overview
    • 7.13.2. Financial Performance
    • 7.13.3. Product Benchmarking
    • 7.13.4. Strategic Initiatives
  • 7.14. BASF SE
    • 7.14.1. Company Overview
    • 7.14.2. Financial Performance
    • 7.14.3. Product Benchmarking
    • 7.14.4. Strategic Initiatives
  • 7.15. Dextra Laboratories Limited
    • 7.15.1. Company Overview
    • 7.15.2. Financial Performance
    • 7.15.3. Product Benchmarking
    • 7.15.4. Strategic Initiatives
  • 7.16. Inboise N.V.
    • 7.16.1. Company Overview
    • 7.16.2. Financial Performance
    • 7.16.3. Product Benchmarking
    • 7.16.4. Strategic Initiatives
  • 7.17. Biosynth Limited
    • 7.17.1. Company Overview
    • 7.17.2. Financial Performance
    • 7.17.3. Product Benchmarking
    • 7.17.4. Strategic Initiatives
  • 7.18. ELICITYL S.A.
    • 7.18.1. Company Overview
    • 7.18.2. Financial Performance
    • 7.18.3. Product Benchmarking
    • 7.18.4. Strategic Initiatives
  • 7.19. ZuChem Inc.
    • 7.19.1. Company Overview
    • 7.19.2. Financial Performance
    • 7.19.3. Product Benchmarking
    • 7.19.4. Strategic Initiatives
  • 7.20. RAJVI ENTERPRISE
    • 7.20.1. Company Overview
    • 7.20.2. Financial Performance
    • 7.20.3. Product Benchmarking
    • 7.20.4. Strategic Initiatives